Brazil Genomics Market Size & Outlook, 2023-2030
Brazil genomics market, 2018-2030 (US$M)
Related Markets
Brazil genomics market highlights
- The Brazil genomics market generated a revenue of USD 971.2 million in 2023 and is expected to reach USD 2,262.2 million by 2030.
- The Brazil market is expected to grow at a CAGR of 12.8% from 2024 to 2030.
- In terms of segment, functional genomics was the largest revenue generating application in 2023.
- Pathway Analysis is the most lucrative application segment registering the fastest growth during the forecast period.
Genomics market data book summary
| Market revenue in 2023 | USD 971.2 million |
| Market revenue in 2030 | USD 2,262.2 million |
| Growth rate | 12.8% (CAGR from 2023 to 2030) |
| Largest segment | Functional genomics |
| Fastest growing segment | Pathway Analysis |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Functional Genomics, Epigenomics, Pathway Analysis, Biomarker Discovery |
| Key market players worldwide | Agilent Technologies Inc, Bio-Rad Laboratories Inc, Danaher Corp, Eppendorf, Eurofins Scientific SE, Roche Holding AG ADR, GE Aerospace, Illumina Inc, Myriad Genetics Inc, Oxford Nanopore Technologies PLC, Pacific Biosciences of California Inc, Qiagen NV, Quest Diagnostics Inc, Thermo Fisher Scientific Inc, 23andMe Holding Co Class A |
Other key industry trends
- In terms of revenue, Brazil accounted for 3.0% of the global genomics market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Latin America, Brazil genomics market is projected to lead the regional market in terms of revenue in 2030.
- Brazil is the fastest growing regional market in Latin America and is projected to reach USD 2,262.2 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Genomics Market Scope
Genomics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Brazil genomics market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to genomics market will help companies and investors design strategic landscapes.
Functional genomics was the largest segment with a revenue share of 32.5% in 2023. Horizon Databook has segmented the Brazil genomics market based on functional genomics, epigenomics, pathway analysis, biomarker discovery covering the revenue growth of each sub-segment from 2018 to 2030.
Brazil is one of the most ethnically diverse and multicultural countries, which creates high demand for gene-level understanding of any given clinical condition. Several initiatives have been undertaken to address this situation.
For instance, DNA do Brasil (DNABr) was launched in 2018 to understand the genetic admixture of the Brazilian population, which could help address key issues about the country’s natural history of health by generating reference genomes based on allele frequencies.
In 2020, primary causes of mortality in Brazil were disorders of the circulatory system, including ischemic heart disease, followed by infectious & parasitic diseases, and then malignant neoplasms. All of these clinical conditions provide solutions through genomics-based strategies. Therefore, many corporates are adopting strategies to expand their genomics-based operations in the region.
Reasons to subscribe to Brazil genomics market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Brazil genomics market databook
-
Our clientele includes a mix of genomics market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Brazil genomics market , including forecasts for subscribers. This country databook contains high-level insights into Brazil genomics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Brazil genomics market size, by application, 2018-2030 (US$M)
Brazil Genomics Market Outlook Share, 2023 & 2030 (US$M)
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
